Patents Represented by Attorney Maureen Gibbons

Find this attorney in the Justia Lawyer Directory

  • Substituted anilide ligands for the thyroid receptor
    Patent number: 7342127
    Abstract: Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.
    Type: Grant
    Filed: January 23, 2004
    Date of Patent: March 11, 2008
    Assignees: Bristol-Myers Squibb Company, Karo Bio AB
    Inventors: William N. Washburn, Wei Meng, Denis E. Ryono, Bruce A. Ellsworth, Thomas Ericsson, Mahmoud Rahimi-Ghadim, Neeraj Garg, Johan Malm
  • Method for reducing toxicity of combined chemotherapies
    Patent number: 6906040
    Abstract: Compositions and methods are provided for use in the treatment of cancer.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: June 14, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Giorgio Minotti, Luca Gianni
  • Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
    Patent number: 6602870
    Abstract: This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin.
    Type: Grant
    Filed: March 7, 2001
    Date of Patent: August 5, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventor: Michel Chazard